Physician profile
Jan D Tepper
NPI 1184666299
$12,492.05
in general payments reported to CMS, 2019-2025
47 companies · $816 in 2025
The $816 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,614 · 2020: $1,173 · 2021: $948 · 2022: $3,015 · 2023: $1,633 · 2024: $292 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,629 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,629.25 |
| Education | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,587.06 | 2021-2023 | |
| Pinnacle Transplant Technologies, LLC | $1,450.89 | 2019-2020 | |
| Integra Lifesciences Corporation | $1,385.43 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $1,146.93 | 2019-2020 | |
| Smith+Nephew, INC. | $847.22 | 2019-2024 | Stravix, Oasis, Grafix |
| Angiodynamics, INC. | $782.56 | 2021-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Melinta Therapeutics, LLC | $607.20 | 2019-2023 | Kimyrsa |
| Horizon Therapeutics Plc | $467.74 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $445.10 | 2021-2025 | Nuzyra |
| Cardiovascular Systems INC. | $344.80 | 2019-2022 | |
| Stryker Corporation | $289.41 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Ortholoc 2 Lapifuse |
| Averitas Pharma INC. | $289.14 | 2023 | Qutenza |
| Grt US Holding, INC. | $284.76 | 2022 | |
| Amgen INC. | $258.89 | 2025 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $245.27 | 2019-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Tepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.